Search Results - "David, Reuben Ben"

Robot‐assisted nephroureterectomy: surgical and mid‐term oncological outcomes in over 1100 patients (ROBUUST 2.0 collaborative group) by Ditonno, Francesco, Franco, Antonio, Wu, Zhenjie, Wang, Linhui, Abdollah, Firas, Simone, Giuseppe, Correa, Andres F., Ferro, Matteo, Perdonà, Sisto, Amparore, Daniele, Bhanvadia, Raj, Brönimann, Stephan, Puri, Dhruv, Mendiola, Dinno F., Ben‐David, Reuben, Moon, Sol C., Yong, Courtney, Moghaddam, Farshad S., Ghoreifi, Alireza, Bologna, Eugenio, Licari, Leslie Claire, Finati, Marco, Tuderti, Gabriele, Helstrom, Emma, Tozzi, Marco, Tufano, Antonio, Rais‐Bahrami, Soroush, Sundaram, Chandru P., Mehrazin, Reza, Gonzalgo, Mark L., Derweesh, Ithaar H., Porpiglia, Francesco, Singla, Nirmish, Margulis, Vitaly, Antonelli, Alessandro, Djaladat, Hooman, Autorino, Riccardo

“…Objective To analyse surgical, functional, and mid‐term oncological outcomes of robot‐assisted nephroureterectomy (RANU) in a contemporary large…”
Get full text

Interassay Variability and Clinical Implications of Five Different Prostate-specific Antigen Assays by Kaufmann, Basil, Pellegrino, Paloma, Zuluaga, Laura, Ben-David, Reuben, Müntener, Michael, Keller, Etienne X., Spanaus, Katharina, von Eckardstein, Arnold, Gorin, Michael A., Poyet, Cédric

“…Despite using the latest generation of PSA tests, significant variations in their results were observed. There is urgent need for standardised calibration…”
Get full text

Impact of COVID‐19 pandemic on patients with obstructing urinary stones complicated by infection by Herzberg, Haim, Savin, Ziv, Lasmanovich, Rinat, Marom, Ron, Ben‐David, Reuben, Mano, Roy, Yossepowitch, Ofer, Sofer, Mario

“…Objective To assess the influence of COVID‐19‐imposed life changes on presentation and outcomes of patients with obstructing urinary stones complicated by…”
Get full text

Novel bladder-sparing approaches in patients with muscle-invasive bladder cancer by Ben-David, Reuben, Galsky, Matthew D., Sfakianos, John P.

“…Muscle-invasive bladder cancer is an aggressive disease, for which neoadjuvant chemotherapy followed by radical cystectomy remains the gold standard treatment…”
Get full text

Undetectable pre-radical cystectomy circulating tumour DNA status predicts improved oncological outcomes by Ben-David, Reuben, Lidagoster, Sarah, Geduldig, Jack, Kolanukuduru, Kaushik P, Elkun, Yuval, Tillu, Neeraja, Mandel, Asher, Almoflihi, Mohammed, Kaufmann, Basil, Attalla, Kyrollis, Mehrazin, Reza, Wiklund, Peter, Sfakianos, John P

“…To assess recurrence-free survival (RFS) in patients with undetectable tumour-informed circulating tumour DNA (ctDNA) before radical cystectomy (RC) and…”
Get full text

Operative techniques and long-term outcomes of hypospadias repair in the absence of preputial skin after neonatal circumcision by Herzberg, Haim, Dubi-Sobol, Adit, Mendelson, Tomer, Ben-David, Reuben, Bar-Yaakov, Noam, Savin, Ziv, Ben-Chaim, Jacob, Bar-Yosef, Yuval

“…•Parents of children born with hypospadias are counseled to refrain from performance of neonatal circumcision.•Results of hypospadias repair following neonatal…”
Get full text

BCG and Alternative Therapies to BCG Therapy for Non-Muscle-Invasive Bladder Cancer by Lidagoster, Sarah, Ben-David, Reuben, De Leon, Benjamin, Sfakianos, John P

“…Bladder cancer is a heterogeneous disease. Treatment decisions are mostly decided based on disease stage (non-muscle invasive or muscle invasive). Patients…”
Get full text

Megameatus intact prepuce variant reconstruction: Long-term outcomes and comparison to post-circumcision hypospadias repair by Herzberg, Haim, Ben-David, Reuben, Mendelson, Tomer, Dubi-Sobol, Adit, Bashi, Tomer, Savin, Ziv, Ben-Chaim, Jacob, Bar-Yosef, Yuval

“…Megameatus intact prepuce (MIP) variant is considered a surgical challenge with associated high complication rates. It is usually diagnosed and corrected only…”
Get full text

Radical cystectomy and perioperative chemotherapy in octogenarians with bladder cancer by Savin, Ziv, Herzberg, Haim, Schreter, Eran, Ben-David, Reuben, Bar-Yosef, Yuval, Sofer, Mario, Beri, Avi, Yossepowitch, Ofer, Mano, Roy

“…We aimed to compare the treatment patterns and oncological outcomes, including postoperative morbidity and chemotherapy use, between octogenarians and patients…”
Get full text

V08-08 THE DIFFICULT NEOBLADDER: TECHNIQUES TO MOBILIZE THE ILEUM TO THE URETHRA by Tillu, Neeraja, Lavallee, Etienne, Ben-David, Reuben, Pathak, Prachee, Sfakianos, John, Mehrazin, Reza, Wiklund, Peter

Get full text

MP61-20 UTILITY OF CIRCULATING TUMOR DNA IN PATIENTS WITH DIFFERENT STAGES OF TESTICULAR CANCER by Ben David, Reuben, Tillu, Neeraja, Galsky, Matthew D., Waingankar, Nikhil, Attalla, Kyrollis, Mehrazin, Reza, Wiklund, Peter, Sfakianos, John P.

Get full text

Tumor-informed circulating tumor DNA in urothelial carcinoma: a promising novel biomarker by Ben-David, Reuben, Mehrazin, Reza, Attalla, Kyrollis, Wiklund, Peter, Sfakianos, John P

“…Tumor-informed circulating tumor DNA (ctDNA) is an emerging biomarker in urothelial carcinoma. Recent clinical trials have investigated the integration of…”
Get full text

GEMCITABINE AND DOCETAXEL INDUCTION ONLY VERSUS INDUCTION WITH MAINTENANCE IN LOW-RISK AND INTERMEDIATE-RISK NON-MUSCLE INVASIVE BLADDER CANCER by David, Reuben Ben, Tillu, Neeraja, Alerasool, Parissa, Attalla, Kyrollis, Waingankar, Nikhil, Wiklund, Peter, Sfakianos, John P.

“…The combination of; gemcitabine and docetaxel (Gem/Doce) as intravesical chemotherapy has been considered as a possible alternative to BCG installations when…”
Get full text

BCG INDUCTION WITH GEMCITABINE/DOCETAXEL MAINTENANCE VS. GEMCITABINE/DOCETAXEL INDUCTION AND MAINTENANCE AS ADJUVANT THERAPY IN NON-MUSCLE INVASIVE BLADDER CANCER by David, Reuben Ben, Tillu, Neeraja, Alerasool, Parissa, Mehrazin, Reza, Wiklund, Peter, Sfakianos, John P.

“…The combination of; gemcitabine and docetaxel (Gem/Doce) as intravesical chemotherapy has been considered as a possible alternative in the adjuvant setting of…”
Get full text

Novel signatures of prostate cancer progression and therapeutic resistance by Wang, Jason, Ben-David, Reuben, Mehrazin, Reza, Yang, Wei, Tewari, Ashutosh K, Kyprianou, Natasha

“…The extensive heterogeneity of prostate cancer (PCa) and multilayered complexity of progression to castration-resistant prostate cancer (CRPC) have contributed…”
Get more information

PD38-01 NEGATIVE CTDNA STATUS PRIOR TO RADICAL CYSTECTOMY PREDICTS IMPROVED OUTCOMES by Ben David, Reuben, Cumarasamy, Shivaram, Alerasool, Parissa, Tillu, Neeraja, Rich, Jordan M., Kaufmann, Basil, Attalla, Kyrollis, Galsky, Matthew D., Mehrazin, Reza, Wiklund, Peter, Sfakianos, John P.

Get full text

MP16-19 COMPARISON OF BCG TO GEMCITABINE/DOCETAXEL IN THE INTERMEDIATE RISK GROUP COMPOSED MOSTLY OF TAHG by Ben-David, Reuben, Alerasool, Parissa, Kolanukuduru, Kaushik P., Tillu, Neeraja, Eisenhauer, Justin, Waingankar, Nikhil, Attalla, Kyrollis, Mehrazin, Reza, Wiklund, Peter, Sfakianos, John P.

Get full text

PD38-07 90-DAY OUTCOMES COMPARING APIXABAN TO ENOXAPARIN FOR THROMBOPROPHYLAXIS AFTER ROBOTIC-ASSISTED RADICAL CYSTECTOMY by Rich, Jordan M., Elkun, Yuval, Geduldig, Jack, Ben-David, Reuben, Tillu, Neeraja, Lavallee, Etienne, Attalla, Kyrollis, Mehrazin, Reza, Wiklund, Peter, Sfakianos, John P.

Get full text

MP22-11 THROMBOEMBOLIC EVENTS AFTER ROBOTIC RADICAL CYSTECTOMY: A COMPARATIVE ANALYSIS OF EXTENDED AND LIMITED PROPHYLAXIS by Rich, Jordan M., Geduldig, Jack, Elkun, Yuval, Tillu, Neeraja, Ben-David, Reuben, Lavallee, Etienne, Attalla, Kyrollis, Mehrazin, Reza, Wiklund, Peter, Sfakianos, John P.

Get full text

PD02-07 POSITIVE CTDNA STATUS BEFORE RADICAL CYSTECTOMY PREDICTS LYMPH NODE STATUS AND PATHOLOGICAL UPSTAGING by Ben-David, Reuben, Cumarasamy, Shivaram, Alerasool, Parissa, Tillu, Neeraja, Rich, Jordan M., Kaufmann, Basil Basil, Attalla, Kyrollis, Galsky, Matthew D., Mehrazin, Reza, Wiklund, Peter, Sfakianos, John P.

Get full text